CapsoVision Inc (CV)
CapsoVision, Inc. is a healthcare company focused on medical imaging technology for gastrointestinal use. The company designs, manufactures, and markets endoscopic video imaging devices, including the CapsoCam Plus capsule endoscopy system for viewing the small bowel mucosa in adults and children aged 2 years and older. It also offers CapsoCam Colon for colon visualization and polyp detection and measurement, while continuing development of CapsoColon 3D for large-intestine imaging. In addition, CapsoVision provides CapsoCloud, a cloud-based software platform for off-premises video access and download, along with CapsoView reading devices, CapsoAccess data access systems, CapsoRetrieve capsule retrieval kits, and capsule video reading services. Its products are used by gastrointestinal medical practices, clinics, and hospitals, and are sold through distributor customers. CapsoVision was incorporated in 2005 and is headquartered in Saratoga, California.
Jump directly to the stock analysis sections supported by the latest available data.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Analyst Target Rating | Overall Financial Health | Dividend Yield | Next Earnings Date | Price-to-Book Ratio | Price-to-Sales Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Payout Ratio | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
NASDAQ-CV
|
$5.33
|
-19.9% Downside
|
Overvalued
|
$9.50
|
42.6% Upside
|
Undervalued
|
Fair
|
0.0%
|
November 12, 2026
|
25.3x
|
24.0x
|
335.3 M
|
324.9 M
|
0.2%
|
62.9%
|
18.6
|
0.0%
|
93.5%
|
